Abstract
The brain is an organ predisposed to oxidative/nitrosative stress. This is especially true in the case of aging as well as several neurodegenerative diseases. Under such circumstances, a decline in the normal antioxidant defense mechanisms leads to an increase in the vulnerability of the brain to the deleterious effects of oxidative damage. Highly reactive oxygen/nitrogen species damage lipids, proteins, and mitochondrial and neuronal genes. Unless antioxidant defenses react appropriately to damage inflicted by radicals, neurons may experience microalteration, microdysfunction, and degeneration. We reviewed how oxidative and nitrosative stresses contribute to the pathogenesis of depressive disorders and reviewed the clinical implications of various antioxidants as future targets for antidepressant treatment.
Original language | English |
---|---|
Pages (from-to) | 224-235 |
Number of pages | 12 |
Journal | Progress in Neuro-Psychopharmacology and Biological Psychiatry |
Volume | 46 |
DOIs | |
Publication status | Published - 2013 Oct 1 |
Externally published | Yes |
Bibliographical note
Funding Information:This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120004) .
Keywords
- Antidepressant
- Depression
- Novel target
- Oxidative/nitrosative stress
ASJC Scopus subject areas
- Pharmacology
- Biological Psychiatry